Anticoagulant and Antiarrhythmic Management Based on Continuous Rhythm Monitoring

Status unconfirmed

Conditions studied: New Onset Atrial Fibrillation

In brief

This pilot study aims to assess the feasibility and safety of using an ILR to identify the incidence of recurrent AF after an episode of newly diagnosed AF. The study further aims to assess the risk of AF recurrence in this low risk population based on left atrial and left atrial appendage anatomic and functional indices in addition to the standardized clinical CHA2DS2-Vasc score.

Key facts

Study ID

NCT04038944

Run by

St. Francis Hospital, New York

People needed

250

Starts

2019-07-17

Expected to finish

2023-09-01

Last updated by the study team

2019-07-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years
• Newly diagnosed AF
• Patient or legal guardian is willing and able to provide informed written consent and comply with follow-up visits and testing schedule

You may not qualify if…

• Patient is participating in or plans to participate in any other investigational drug or device clinical trial that has not reached its primary endpoint
• Patient received an organ transplant, or is on a waiting list.
• Patient is not able to follow instructions for remote monitoring 4 Prior history of AF

Where it is running

• St Francis Hospital — Roslyn, New York, United States (enrolling)
• St. Francis Hospital — Roslyn, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.